This month VacZine Analytics, a specialist in infectious diseases and vaccines commercial analysis, publishes a brand-new ...

Acne vulgaris is a chronic inflammatory skin condition that primarily affects the pilosebaceous unit, leading to the development of non-inflammatory lesions such as comedones and inflammatory ...

A combination of nicotinamide (750 mg), zinc oxide (25 mg), and folic acid (500 µg) is approved for the treatment of acne vulgaris (and rosacea). Both nicotinamide and zinc oxide have anti ...

Back acne, sometimes called "bacne," can be treated with a combination of home remedies, lifestyle and dietary changes, and ...

nonusers. Women were 53% more likely to develop acne vulgaris 1 year after starting the drug. Glucagon-like peptide-1 receptor agonists, an increasingly popular class of weight loss medications ...

Kane to work with the University of Miami to study DispersinB® Acne Cleanser in mild to moderate Acne VulgarisWINNIPEG, ...

Isotretinoin is indicated for nodular acne or severe acne that is unresponsive to conventional therapies. The usual dose is 0.5 to 1.0 mg/kg/day for 20 weeks, or a cumulative dose of 120 mg/kg.

Muhaidat J, Qablan A, Gharaibeh F, et al. The effect of whey protein supplements on acne vulgaris among male adolescents and young adults: A case-control study from north of Jordan. Dermatol Res ...

and the significant decreases in inflammatory and non-inflammatory lesion counts after 12 weeks of treatment shown in a Phase ...

At-home light-emitting diode (LED) devices are effective for treating acne, according to a research letter published online March 5 in JAMA Dermatology.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

WINNIPEG, Manitoba, March 13, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) ("Kane Biotech" or "Kane") announces today that it has received approval from the Internal Review ...